Next, we investigated whether cancer stem cell markers and function could be manipulated by directly disrupting β-catenin making use of doxycycline (DOX) inducible short-hairpin RNA targeting CTNNB1 (β-catenin) transcripts in 468’R cells (iCTNNB1-KD) (55). This evidence concerns the gene CTNNB1 and cancer.